These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28126427)

  • 1. Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis.
    Peiseler M; Liebscher T; Sebode M; Zenouzi R; Hartl J; Ehlken H; Pannicke N; Weiler-Normann C; Lohse AW; Schramm C
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):260-267.e1. PubMed ID: 28126427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
    Than NN; Wiegard C; Weiler-Normann C; Füssel K; Mann J; Hodson J; Hirschfield GM; Lohse AW; Adams DH; Schramm C; Oo YH
    Scand J Gastroenterol; 2016 Mar; 51(3):329-36. PubMed ID: 26458216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.
    Woynarowski M; Nemeth A; Baruch Y; Koletzko S; Melter M; Rodeck B; Strassburg CP; Pröls M; Woźniak M; Manns MP;
    J Pediatr; 2013 Nov; 163(5):1347-53.e1. PubMed ID: 23810723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-laboratory study on children with auto-immune hepatitis in Upper Egypt.
    Abu Faddan NH; Abdel-Baky L; Aly SA; Rashed HA
    Arab J Gastroenterol; 2011 Dec; 12(4):178-83. PubMed ID: 22305497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of budesonide in the treatment of autoimmune hepatitis in Canada.
    Zandieh I; Krygier D; Wong V; Howard J; Worobetz L; Minuk G; Witt-Sullivan H; Yoshida EM
    Can J Gastroenterol; 2008 Apr; 22(4):388-92. PubMed ID: 18414714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for autoimmune hepatitis.
    Manns MP; Strassburg CP
    Dig Dis; 2011; 29(4):411-5. PubMed ID: 21894012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis.
    Manns MP; Woynarowski M; Kreisel W; Lurie Y; Rust C; Zuckerman E; Bahr MJ; Günther R; Hultcrantz RW; Spengler U; Lohse AW; Szalay F; Färkkilä M; Pröls M; Strassburg CP;
    Gastroenterology; 2010 Oct; 139(4):1198-206. PubMed ID: 20600032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Response and Outcome with Two Different Prednisolone Regimens in Autoimmune Hepatitis.
    Purnak T; Efe C; Kav T; Wahlin S; Ozaslan E
    Dig Dis Sci; 2017 Oct; 62(10):2900-2907. PubMed ID: 28871464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard Treatment in Adults: Which Steroid? Or without Steroids?
    Gleeson D
    Dig Dis; 2015; 33 Suppl 2():75-82. PubMed ID: 26640942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
    Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autoimmune hepatitis: importance of budesonide in intolerance to prednisolone].
    Audeguy P; Signoret C
    Presse Med; 1999 Jan; 28(4):176. PubMed ID: 10071629
    [No Abstract]   [Full Text] [Related]  

  • 12. [3rd place in the competition of scientific work in hepatology in 2010. Treatment of patients with overlap of primary biliary cirrhosis and autoimmune hepatitis].
    Golovanova EV
    Eksp Klin Gastroenterol; 2011; (9):140-8. PubMed ID: 22629792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis.
    Wang Q; Selmi C; Zhou X; Qiu D; Li Z; Miao Q; Chen X; Wang J; Krawitt EL; Gershwin ME; Han Y; Ma X
    J Autoimmun; 2013 Mar; 41():140-5. PubMed ID: 23187010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis.
    Efe C; Hagström H; Ytting H; Bhanji RA; Müller NF; Wang Q; Purnak T; Muratori L; Werner M; Marschall HU; Muratori P; Gunşar F; Klintman D; Parés A; Heurgué-Berlot A; Schiano TD; Cengiz M; May-Sien Tana M; Ma X; Montano-Loza AJ; Berg T; Verma S; Larsen FS; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1950-1956.e1. PubMed ID: 28603052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients.
    Zachou K; Gatselis N; Papadamou G; Rigopoulou EI; Dalekos GN
    J Hepatol; 2011 Sep; 55(3):636-646. PubMed ID: 21238519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis.
    Pape S; Gevers TJG; Belias M; Mustafajev IF; Vrolijk JM; van Hoek B; Bouma G; van Nieuwkerk CMJ; Hartl J; Schramm C; Lohse AW; Taubert R; Jaeckel E; Manns MP; Papp M; Stickel F; Heneghan MA; Drenth JPH
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2068-2075.e2. PubMed ID: 30625402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budesonide induces complete remission in autoimmune hepatitis.
    Csepregi A; Röcken C; Treiber G; Malfertheiner P
    World J Gastroenterol; 2006 Mar; 12(9):1362-6. PubMed ID: 16552802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
    Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil.
    Liberal R; Gaspar R; Lopes S; Macedo G
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101487. PubMed ID: 32651078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study.
    Ferre-Aracil C; Riveiro-Barciela M; Trapero-Marugán M; Rodríguez-Perálvarez M; Llovet LP; Téllez L; Sánchez-Torrijos Y; Díaz-Fontenla F; Salcedo-Plaza M; Álvarez-López P; de la Mata M; Londoño MC; Bañares-Cañizares R; Calleja JL
    Dig Dis Sci; 2021 Aug; 66(8):2826-2832. PubMed ID: 32860579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.